Location: United States, California, San Diego
Employees: 11-50
Total raised: $13M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Biobrit | biobrit.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.07.2021 | - | $13M | - |
Mentions in press and media 5
| Date | Title | Description |
| 20.07.2021 | ProciseDx Raises $13M in Convertible Note Financing | ProciseDx, a San Diego CA-based in vitro diagnostics (IVD) company, raised $13M in convertible note financing. Participants included existing major shareholders (Nestlé Heath Science, Biosynex SA) management and new investors. The company i... |
| 21.07.2020 | ProciseDx : Secures $10.5 Million Series A Financing Round Led by Biosynex, Forms an Independent Point-Of-Care Diagnostic Company | SAN DIEGO, July 21, 2020 /PRNewswire/ -- ProciseDx Inc. has raised $10.5m through $8.5m of equity and $2m of debt, to fund ongoing development and commercialization of its point-of-care (POC) diagnostic platform. The investment round was le... |
| 21.07.2020 | ProciseDx Raises $10.5M in Series A Financing | ProciseDx Inc., a San Diego, CA-based Rapid Diagnostic Tests (TDRs) company, raised $10.5m in Series A funding. The round, which included $8.5m of equity and $2m of debt, was led by Biosynex, S.A., a French diagnostics company, which will n... |
| 21.07.2020 | ProciseDx Raises $10.5M | SAN DIEGO, CA, ProciseDx has raised $10.5 million through $8.5 million of equity and $2 million of debt. >> Click here for more funding data on ProciseDx >> To export ProciseDx funding data to PDF and Excel, click here Th... |
| 21.07.2020 | ProciseDx has secured a $10.5M Series A to continue funding development and commercialization of its point-of-care diagnostic platform | - |